from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3317/sdhD

LFCtreatmentdescriptionclass of inhibitor

-0.620

Amikacinug/mL Amikacintranslation

-0.305

Cap5-10ug/mL Capreomycintranslation

-1.437

Rox10-50 ug/mL Roxithromycintranslation

-0.683

SM2-5 ug/mL Streptomycintranslation

-1.164

Tet5-10 ug/mL Tetracyclinetranslation

0.891

Rif0.2-5ug/mL Rifampicintranscription

0.435

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.308

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.052

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.011

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.533

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.424

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.227

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.193

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.622

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.079

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.106

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.203

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.264

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.614

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.141

KCN5-20 ug/mL Potassium cyaniderespiration

-0.011

NaN30.2-2 mM Sodium aziderespiration

0.007

Nigericin50 uM Nigericinrespiration

0.352

TRC10-150 ug/mL Triclosanrespiration

0.209

TRZ10-25 ug/mL Thioridazinerespiration

-0.984

Valinomycin0.5-10 uM Valinomycinrespiration

-1.511

ZnSO42 mM ZnSO4respiration

0.497

menadione6-10 ug/mL Menadionerespiration

0.016

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.201

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.548

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.238

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.265

NRP_1Non-replicating persistence stage 1dosRassociated

0.151

Amp0.2mg/mL AmpicillincellWall

-0.614

Cephalexin20-100 ug/mL CephalexincellWall

0.034

Cerulenin0.32-5 ug/mL CerulenincellWall

1.014

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.086

EMB10-20 ug/mL EthambutolcellWall

-1.040

Eta12-40 ug/mL EthionamidecellWall

-1.347

INH0.2-0.4 ug/mL IsoniazidcellWall

0.704

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.058

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.004

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.174

BZA0.12 mg/mL BenzamidearomaticAmides

-0.133

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.513

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.486

H2O24 mM hydrogen peroxideDNAdamaging

0.382

Levo10 ug/mL LevofloxacinDNAdamaging

0.454

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.907

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.221

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.396

UVUV-irradiationDNAdamaging

0.807

ARP41-4 ug/mL Antitubercular compound ARP4?

0.644

Antimycin12.5-50 ug/mL Antimycin A?

0.838

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.002

PA_110-50 ug/mL Antitubercular compound PA-1?

0.683

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.458

PA8240.2-2 ug/mL PA-824?

-0.928

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.469

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.131

Verapamil50 uM Verapamil?

0.572

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.026

methoxatin10-20 ug/mL Methoxatin?